Another study using a prostate carcinoma line demonstrated that NCAD-catenin adhesion complex results in up-regulation of the anti-apoptotic protein Bcl-2, whereas the level of the proapoptotic protein Bax remained constant. The gene discussed is BCL2; the disease is prostate carcinoma.